FRST vs MRNA · P/E 8.1, rev $109.8M vs rev $145.0M
Primis Financial Corp (FRST) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Primis Financial Corp (FRST) is a banks - regional company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported FRST revenue for 2026-06-30 was $109.8M. Net income was $16.7M. FRST currently screens at market cap $377.3M and trailing P/E 8.1.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
FRST currently screens at market cap $377.3M and trailing P/E 8.1. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the FRST and MRNA stock pages for the full models.
Not investment advice.